2-20447683-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_004040.4(RHOB):c.218C>T(p.Ser73Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 33)
Consequence
RHOB
NM_004040.4 missense
NM_004040.4 missense
Scores
5
11
3
Clinical Significance
Conservation
PhyloP100: 7.75
Genes affected
RHOB (HGNC:668): (ras homolog family member B) Predicted to enable GTP binding activity; GTPase activity; and protein kinase binding activity. Involved in several processes, including cellular response to hydrogen peroxide; cellular response to ionizing radiation; and regulation of cell migration. Located in cleavage furrow and endosome membrane. Biomarker of breast cancer. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.869
PP5
Variant 2-20447683-C-T is Pathogenic according to our data. Variant chr2-20447683-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1344805.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=2, Uncertain_significance=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RHOB | NM_004040.4 | c.218C>T | p.Ser73Phe | missense_variant | 1/1 | ENST00000272233.6 | NP_004031.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RHOB | ENST00000272233.6 | c.218C>T | p.Ser73Phe | missense_variant | 1/1 | NM_004040.4 | ENSP00000272233 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
"See Cases" Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Wangler Lab, Baylor College of Medicine | - | This missense RHOB variant at c.218C>T (p.S73F) was seen on exome through the Texome project (R01HG011795). This variant is de novo in the affected patient (PS2), and it was previously reported as a de novo change in two individuals with RHOB-related disorder (PMID:32989326). This variant has not been observed in gnomAD (PM2). Functional studies suggest this variant has a functionally defective gain-of-function mechanism (PS3).This missense variant has an inconclusive CADD score (23.400) and the evolutionary conservation of this residue is high. We predict this variant to be likely pathogenic. - |
RHOB-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 25, 2022 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.218C>T (p.S73F) alteration is located in coding exon 1 of the RHOB gene. This alteration results from a C to T substitution at nucleotide position 218, causing the serine (S) at amino acid position 73 to be replaced by a phenylalanine (F). Based on data from the Genome Aggregation Database (gnomAD), the RHOB c.218C>T alteration was not observed, with coverage at this position. This alteration has been described to occur de novo in two unrelated individuals with spastic-dystonic diplegia, expressive language disorder, aortic arch abnormalities, and MRI findings of hyperintense T2 white matter signal (periventricular leukomalacia) (Jin, 2020). The p.S73 amino acid is conserved in available vertebrate species. Biochemical analysis observed protein with the c.218C>T (p.S73F) enhanced GTP hydrolysis and binding as well as accentuated responses to GDP exchange factors (Jin, 2020). The p.S73F alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Recurrent pancreatitis Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Yale Center for Mendelian Genomics, Yale University | Sep 28, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Uncertain
T
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Benign
T
Polyphen
P
Vest4
MutPred
Loss of disorder (P = 0.0245);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.